Predictive factors for the benefit of triple ‐drug transarterial chemoembolization for patients with unresectable hepatocellular carcinoma

ConclusionsTriple ‐drug TACE seems to benefit patients with HCC larger than 10 cm in particular compared with single‐drug TACE.

Source: Cancer Medicine - June 16, 2019 Category: Cancer & Oncology Authors: MinKe He, Qing Li, JingXian Shen, GuoSheng Tan, QiJiong Li, JiaYing Lai, Wei Wei, YaoJun Zhang, RuHai Zou, MinShan Chen, RongPing Guo, Ming Shi Tags: ORIGINAL RESEARCH Source Type: research